IL6 and medical procedure: Evidence consistently demonstrated that redox-sensitive pathways-including NF-κB, NRF2, and IL-6/JAK/STAT3-drive colorectal carcinogenesis by promoting genomic instability, immune evasion, angiogenesis, and therapy resistance.